VitriVax announces Series A financing to further demonstrate feasibility of its thermostable, single-dose vaccine technology, aiming to make life-saving biologics widely accessible to underserved populations globally
Redirecting to:
The Newsroom
Media Inquiries
For marketing and communication inquiries or news tips, contact Daniel Leonard,Ìýsenior marketing and communications specialist for Venture Partners at CU ¶¶Òõ´«Ã½ÔÚÏß.
For media inquiries, please visit .